Author Topic: (Abst.) Stopping disease-modifying therapy in nonrelapsing MS  (Read 44 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8568
  • MS diagnosed 1980
  • Location: Pacific Northwest
The people with SPMS under discussion here who safely stopped taking DMTs seem to have been 70 years old or older. From PubMed, March 1, 2017:

Quote
Int J MS Care. 2017 Jan-Feb;19(1):11-14.

Stopping Disease-Modifying Therapy in Nonrelapsing Multiple Sclerosis: Experience from a Clinical Practice

Birnbaum G.

BACKGROUND:

Current disease-modifying therapies (DMTs) are of benefit only in people with relapsing forms of multiple sclerosis (RMS). Thus, safely stopping DMTs in people with secondary progressive MS may be possible.

METHODS:

Two groups of patients with MS were studied. Group A consisted of 77 patients with secondary progressive MS and no evidence of acute central nervous system inflammation for 2 to 20 years. These patients were advised to stop DMTs. Group B consisted of 17 individuals with RMS who stopped DMTs on their own. Both groups were evaluated at treatment cessation and for a minimum of 1 year thereafter. Multiple variables were assessed to determine those that predicted recurrent acute disease.

RESULTS:

Nine patients in group A (11.7%) and ten patients in group B (58.8%) had recurrent acute disease, almost always within 1 to 2 years of stopping treatment. The only variable of significance in group A distinguishing stable and relapsing patients was age (P = .0003), with relapsing patients being younger. Group B patients were younger and had significantly lower Expanded Disability Status Scale scores than group A, with no significant differences in age between relapsed and stable patients.

CONCLUSIONS:

The DMTs can be stopped safely in older patients with MS (≥7 decades) with no evidence of acute disease for 2 years or longer, with an almost 90% probability of remaining free of acute recurrence. The high proportion of untreated patients with RMS experiencing recurrent acute disease is consistent with published data.
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
67 Views
Last post July 01, 2016, 04:29:22 pm
by agate
0 Replies
204 Views
Last post February 06, 2017, 08:52:28 pm
by agate
0 Replies
44 Views
Last post October 29, 2017, 03:38:47 pm
by agate
0 Replies
56 Views
Last post January 10, 2018, 04:41:40 pm
by agate
0 Replies
23 Views
Last post December 22, 2019, 08:50:14 pm
by agate